BHRT as the Foundation for Peptide Therapy Practice

Peptide therapy is one of the fastest-growing areas in functional and regenerative medicine, but peptides do not replace hormone optimization — they work alongside it. Compounds like sermorelin, ipamorelin, CJC-1295, and BPC-157 modulate growth hormone, tissue repair, and recovery pathways, but their effectiveness depends on a properly balanced endocrine baseline. Providers who prescribe peptides without first assessing testosterone, estrogen, thyroid, and cortisol levels are working blind.

This BHRT certification course gives you the hormone testing and prescribing foundation that responsible peptide practice requires. Once you understand salivary hormone assessment, adrenal fatigue, thyroid optimization, and BHRT protocols for male and female patients, you have the diagnostic framework needed to evaluate whether peptide therapy is appropriate, safe, and effective for any given patient — and to monitor results objectively rather than by symptom alone.

Why Hormone Balancing Should Come Before Peptides

• Growth hormone peptides (sermorelin, ipamorelin, CJC-1295) work downstream of thyroid and cortisol — untreated hypothyroidism or adrenal dysfunction will blunt peptide response.
• BPC-157 and tissue repair peptides are commonly prescribed for recovery, but chronic cortisol elevation (assessable via saliva testing) impairs the healing they’re meant to accelerate.
• Sexual function peptides like PT-141 are often prescribed for symptoms that originate in untreated testosterone or estrogen imbalances — issues that BHRT addresses at the source.
• Patient safety requires baseline hormone testing before introducing any modulating compound. Peptides without hormone testing is the same mistake as prescribing antidepressants without checking thyroid.
• Insurance and regulatory environment for peptides remains unsettled. BHRT is established, accredited, and defensible — a stable practice revenue line that complements peptide offerings without depending on them.

PracticalCME does not currently offer a dedicated peptide prescribing course. We believe hormone optimization, properly tested and properly treated, is the foundation every functional medicine practice should master first. Providers who complete our BHRT certification are significantly better positioned to evaluate, integrate, and monitor peptide therapies if and when they choose to add them.

Does this course cover peptide therapy?

This course focuses on bioidentical hormone replacement and salivary hormone testing — the foundational diagnostic and prescribing framework that any peptide therapy practice should be built on. While we do not teach specific peptide prescribing protocols, the BHRT certification equips you with the hormone testing skills, endocrine pathway understanding, and treatment monitoring methods required to evaluate whether peptides are appropriate for your patients and to monitor their effectiveness objectively.

Should I take BHRT training before learning peptide therapy?

Yes. Peptides like sermorelin, ipamorelin, CJC-1295, and BPC-157 work on hormonal and tissue repair pathways that depend on baseline endocrine function. Prescribing growth hormone peptides to a patient with untreated hypothyroidism or adrenal fatigue produces unpredictable results. BHRT certification gives you the diagnostic foundation to assess and correct hormone imbalances first, which makes any subsequent peptide therapy safer and more effective.

How does BHRT relate to growth hormone peptides like sermorelin and ipamorelin?

Growth hormone-releasing peptides stimulate the pituitary to release endogenous growth hormone, but the downstream effects depend on a properly functioning thyroid and adrenal system. Patients with low free T3 or chronic cortisol elevation often show blunted response to growth hormone peptides. The BHRT course teaches comprehensive thyroid and adrenal assessment, which is essential context for any provider considering growth hormone peptide protocols.

Is BHRT still relevant with peptide therapy becoming popular?

BHRT is more relevant than ever. Peptides are adjunct therapies — they modulate specific pathways but do not replace the testosterone, estrogen, thyroid, and cortisol fundamentals. Practices building peptide programs without solid BHRT competency frequently produce inconsistent patient outcomes. BHRT remains the foundation; peptides are one of several optimization layers built on top of it.

Why does PracticalCME teach saliva testing instead of serum blood testing?

Saliva testing measures the free, biologically active fraction of steroid hormones — the portion actually available to tissues — while serum blood tests measure total hormone bound to carrier proteins. For monitoring topical bioidentical creams in particular, saliva is the validated method; serum levels can appear normal or even low while tissue levels are excessive, leading to dosing errors. The course covers when serum, saliva, and urine testing each have a role, so you understand the tradeoffs rather than relying on a single method.

Can I prescribe bioidentical hormones if I’m not in a state that allows compounding?

Yes. Many bioidentical hormones — including estradiol, progesterone, testosterone, and thyroid preparations like Armour Thyroid and Cytomel — are available as FDA-approved commercial products that any licensed prescriber can order through standard pharmacies. The course covers both commercial and compounded options, so you can build a BHRT practice whether or not you choose to work with a compounding pharmacy. Compounded preparations expand your dosing flexibility but are not required to practice BHRT.

How is this BHRT course different from A4M, AFMA, or Worldlink Medical training?

PracticalCME has taught BHRT since 2008 and is the only accredited BHRT certification that integrates female, male, thyroid, and adrenal testing in a single evidence-based online course. Most competitor programs separate these into multiple modules or require live attendance over multiple weekends. Our course is fully online, self-paced, includes 8 AAFP CME credits, two years of unlimited access with free updates, customizable patient forms, and direct email support from the medical director for help interpreting your first cases. Pricing is transparent and substantially lower than multi-weekend live programs.

What does the course cover beyond hormone testing and prescribing?

The course is built for practice implementation, not just clinical theory. You receive customizable office intake forms, patient history templates, treatment tracking sheets, and patient education handouts that you can brand and use immediately. The training also covers the business side: how to position BHRT in your practice, how to talk to patients about salivary testing, how to handle insurance questions, and how to structure follow-up visits for hormone monitoring. By the end of the course you have both the clinical knowledge and the operational infrastructure to start treating patients.

How long does the online BHRT course take to complete?

The course runs approximately 8 hours of video content and is fully self-paced. Most providers complete it over one to two weeks, watching modules in 60- to 90-minute sessions. Your login remains active for two full years from purchase, with free updates pushed to your account as new research and protocols evolve. You can revisit any module as often as needed while building your BHRT practice, and the post-test for CME credit can be taken when you’re ready.

Will I be able to interpret my first patient’s saliva test results after this course?

Yes. The course includes extensive case studies with practice interpreting actual test results and formulating treatment plans for male, female, thyroid, and adrenal presentations. You’ll work through real patient scenarios — perimenopausal women, andropausal men, adrenal fatigue patterns, subclinical hypothyroidism — and learn to recognize which lab patterns require which interventions. After the course, you also have email support from the medical director to help you work through your first few cases in practice, which is something no other online BHRT program offers.

Is BHRT certification recognized by hospitals, insurance carriers, or licensing boards?

BHRT is a clinical skill, not a separate licensure category, so no state board issues a “BHRT license.” What this course provides is ACCME-accredited continuing medical education — 8 CME credits from AAFP that count toward your standard CME requirements for license renewal, hospital privileging, and board recertification. The certificate documents that you completed accredited training in bioidentical hormone therapy, which is the credential providers display in their practice and reference in patient consultations. Scope of practice for prescribing remains determined by your underlying license.